A previous study showed that the combinatory treatment of 15-PGDH gene therapy and COX-2 inhibitor significantly inhibits murine breast tumor growth and tumor angiogenesis compared with monotherapy or controls (37). The gene discussed is PTGS2; the disease is breast neoplasm.